The NSCLC-enriched fractions had similar profiles to the GBM-enriched fraction of platelets, corresponding to the activated subtype, with high levels of ACTB, ITGA2B, MYL6, and GP1BB; the NSCLC-depleted fraction had high levels of RGS18 similar to the GBM-depleted fraction. This evidence concerns the gene GP1BB and non-small cell lung carcinoma.